Evidence map›Paper›PMID 26038351›Full record

ReviewNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2015

Incremental haemodialysis.

Jonathan Wong, Enric Vilar, Andrew Davenport, Ken Farrington

3 registry-linked trialsOpen access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03239808 naactive not recruitingnot on this mapstarted 2018, after this paper: background citation

Assessment of the Incremental Haemodialysis Security and Effectiveness in Incident Patients

TypeinterventionalSponsorFundación para la Formación e Investigación de los Profesionales de la Salud de ExtremaduraRan2018 to 2025Enrolled152ConditionsRenal Disease, End-StageArmsIncremental haemodialysis, Conventional haemodialysis
NCT03352271 nacompletednot on this mapstarted 2017, after this paper: background citation

Comparison of Clinical Outcomes Between Thrice-weekly and Individualized Incremental Hemodialysis in Incident Hemodialysis Patients

TypeinterventionalSponsorAlexandria UniversityRan2017 to 2020Enrolled122ConditionsHemodialysis Complication, ESRD, Renal FailureArmsIndividualized Incremental hemodialysis, Conventional thrice weekly hemodialysis
NCT06243900 unknown statusnot on this mapstarted 2024, after this paper: background citation

NIRS: a Tool for the Diagnosis of Residual Renal Function Injury in Hemodialysis Patients

TypeobservationalSponsorYuanjun YangRan2024 to 2026Enrolled30ConditionsEnd-stage Renal Disease (ESRD)
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Impact of incremental initiation of haemodialysis on mortality: a systematic review and meta-analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Pooled it
  3. Pooled it
  4. Guideline
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study.Therapeutics and clinical risk management · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jonathan WongRenal Unit, Lister Hospital, Stevenage, Hertfordshire, UK Department of Postgraduate Medicine, University of Hertfordshire, Hatfield, Hertfordshire, UK.
Enric VilarRenal Unit, Lister Hospital, Stevenage, Hertfordshire, UK Department of Postgraduate Medicine, University of Hertfordshire, Hatfield, Hertfordshire, UK.
Andrew DavenportUCL Centre for Nephrology, Royal Free Hospital, London, UK University College London Medical School, London, UK.
Ken FarringtonRenal Unit, Lister Hospital, Stevenage, Hertfordshire, UK Department of Postgraduate Medicine, University of Hertfordshire, Hatfield, Hertfordshire, UK.
University of Hertfordshire · GBLister Hospital · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrice-weekly haemodialysis schedules have become the standard default haemodialysis prescription worldwide. Whereas the measurement of residual renal function is accepted practice for peritoneal dialysis patients and the importance of residual renal function in determining technique success is well established, few centres routinely assess residual renal function in haemodialysis patients. Although intradialytic hypotension and episodes of acute kidney injury may predispose to an earlier loss of residual renal function, a significant proportion of haemodialysis patients maintain some residual function long after dialysis initiation. As such, an incremental approach to the initiation of dialysis with careful monitoring of residual renal function may potentially provide some haemodialysis patients with an improved quality of life and greater preservation of residual renal function whilst fewer dialysis sessions may reduce health care costs. Prospective trials are required to determine the optimum approach to the initiation of haemodialysis for the oliguric patient. Once residual renal function has been lost, then dialysis prescriptions should be re-examined to consider the use of longer or more frequent treatment sessions and switching from low-flux to high-flux dialysis or haemodiafiltration to offset retention of middle sized molecules and protein-bound azotaemic solutes.

Indexed as

Quality of LifeHumansKidney Failure, ChronicRenal DialysisTime FactorshaemodiafiltrationhaemodialysishypotensionKt/Vresidual renal function

Identifiers

PMID26038351
OpenAlexW4231509610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.